TRVI · Trevi Therapeutics, Inc. · Share Buybacks
$13.49
-0.23 (-1.68%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$1.96B
Shares
142.56M
Volume · Nov 20
1.37M
Avg daily vol (3M)
1.97M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2023-06 | 2025-11 | $200,000,000 | — | — | 10-Q , filed 2026-08-06 |
Key facts
CIK
1563880
CUSIP
89532M101
13F (30d)
230 filings
216 filers
Visit website
Investor relations